Diffuse alveolar hemorrhage: Unusual presentation of systemic lupus erythematosus
Article Sidebar
Main Article Content
Abstract
Diffuse alveolar hemorrhage (DAH) is a rare complication of systemic lupus erythematosus (SLE) and carries a high mortality.
It was first described by Osler in 1904 as the most devastating pulmonary complication of SLE.
We describe a case of a 23-year-old girl recently diagnosed with SLE associated by a class III nephritis treated with oral corticoids and mycophenolate mofetil who developed a Diffuse Alveolar Hemorrhage DAH a few days later. The early diagnosis and the aggressive therapy allowed us to have a favorable outcome.
Article Details
Copyright (c) 2021 Yassir Z, et al.
This work is licensed under a Creative Commons Attribution 4.0 International License.
The Journal of Clinical Nephrology is committed in making it easier for people to share and build upon the work of others while maintaining consistency with the rules of copyright. In order to use the Open Access paradigm to the maximum extent in true terms as free of charge online access along with usage right, we grant usage rights through the use of specific Creative Commons license.
License: Copyright © 2017 - 2025 | 
Open Access by Journal of Clinical Nephrology is licensed under a Creative Commons Attribution 4.0 International License. Based on a work at Heighten Science Publications Inc.
With this license, the authors are allowed that after publishing with the journal, they can share their research by posting a free draft copy of their article to any repository or website.
Compliance 'CC BY' license helps in:
| Permission to read and download | ✓ |
| Permission to display in a repository | ✓ |
| Permission to translate | ✓ |
| Commercial uses of manuscript | ✓ |
'CC' stands for Creative Commons license. 'BY' symbolizes that users have provided attribution to the creator that the published manuscripts can be used or shared. This license allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author.
Please take in notification that Creative Commons user licenses are non-revocable. We recommend authors to check if their funding body requires a specific license.
Zamora MR, Warner ML, Tuder R, Schwarz MI. Diffuse alveolar hemorrhage and systemic lupus erythematosus: clinical presentation, histology, survival, and outcome. Medicine. 1997; 76: 192-202. PubMed: https://pubmed.ncbi.nlm.nih.gov/9193454/
Hunninghake GW, Fauci AS. Pulmonary involvement in the collagen vascular diseases. Am Rev Respir Dis.1979; 119: 471-503.
Emlen W. Systemic lupus erythematosus and mixed connective tissue disease. Immunol Allergy Clin North America. 1993; 13: 291–311.
Santiago-Casas Y, Vila LM. Pulmonary hemorrhage in patients with systemic lupus erythematosus. Curr Respir Med Rev. 2009; 5: 49-54.
Kamen DL, Strange C. Pulmonary manifestations of systemic lupus erythematosus. Clin Chest Med. 2010; 31:479-488. PubMed: https://pubmed.ncbi.nlm.nih.gov/20692540/
Koh WH, Thumboo J, Boey ML. Pulmonary haemorrhage in oriental patients with systemic lupus erythematosus. Lupus 1997; 6: 713–716.
Badsha H, Teh CL, Kong KO, Lian TY, Chng HH. Pulmonary hemorrhage in systemic lupus erythematosus. Semin Arthritis Rheum 2004; 33: 414–421. PubMed: https://pubmed.ncbi.nlm.nih.gov/15190526/
Olser W. On the visceral manifestations of the erythema group of skin diseases. Am J Med Sci. 2009; 338: 396–408. PubMed: https://pubmed.ncbi.nlm.nih.gov/19938295/
Alabed LB. Treatment of Diffuse Alveolar Hemorrhage in Systemic Lupus Erythematosus Patient with Local Pulmonary Administration of Factor VIIa (rFVIIa) A Case Report. Medicine. 2014; 93: 14. PubMed: https://pubmed.ncbi.nlm.nih.gov/25255019/
Liu MF, Lee JH, Weng TH, Lee YY. Clinical experience of 13 cases with severe pulmonary hemorrhage in systemic lupus erythematosus with active nephritis. Scand J Rheumatol. 1998; 27: 291–295.
Martınez-Martınez MU, Abud-Mendoza C. Diffuse alveolar hemorrhage in patients with systemic lupus erythematosus. Clinical manifestations, treatment, and prognosis. Reumatol Clin. 2014; 10: 248–253.
Marten K, Schnyder P, Schirg E, Prokop M, Rummeny EJ, et al. Pattern-based differential diagnosis in pulmonary vasculitis using volumetric CT. Am J Roentgenol 2005; 184: 720–733.
Hoshi KI, Matsuda M, Ishikawa M, Mitsuhashi S, Gono T, et al. Successful treatment of fulminant pulmonary hemorrhage associated with systemic lupus erythematosus. Clin Rheumatol. 2004; 23: 252-255.
Huang DF,Tsai TS, Wang SR. Recovery of both acute massive pulmonary hemorrhage and acute renal failure in a systemic lupus erythematosus patient with lupus anticoagulant by the combined therapy of plasmapheresis plus cyclophosphamide. Transfusion Science. 1994; 15: 283-288.
Claridge S, Das P, Dorling A, Robson M. Plasmapheresis as rescue therapy for systemic lupus erthyematosus associated diffuse alveolar haemorrhage. BMJ Case Rep. 2011; 2011. PubMed: https://pubmed.ncbi.nlm.nih.gov/22698899/
Na JO, Chang SH, Seo KH, Sung Choi J, Sung Lee H. et al. Successful Early Rituximab Treatment in a Case of Systemic Lupus Erythematosus with Potentially Fatal Diffuse Alveolar Hemorrhage. Respiration. 2015; 89: 62–65.
Estella A, Jareno A, Perez-Bello L. Intrapulmonary administration of recombinant activated factor VII in diffuse alveolar haemorrhage: a report of two case. Cases J. 2008 12; 1: 150. PubMed: https://pubmed.ncbi.nlm.nih.gov/18789132/